Basic Information
HVR Cardio is a cardiovascular device company. HVR Cardio is developing transcatheter mitral valve repair technology, its CathHELIX™ annuloplasty system, for structural heart physicians to treat mitral regurgitation (MR). Our mission is to develop solutions for mitral valve interventions that are faster, easier to use, less invasive, and do not compromise clinical efficacy.
HVR Cardio International Ltd Oy
Finland
unclear
--
tom@medtentia.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios

